Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.03% | 36.71 | 0.9% | $1161.89m | |
| JNJ | Johnson & Johnson | -0.01% | 160.28 | 0.7% | $1077.05m | |
| LLY | Eli Lilly & Co. | 0.01% | 190.79 | 1.1% | $703.48m | |
| ABBV | AbbVie, Inc. | -0.03% | 110.49 | 1.9% | $703.16m | |
| MRK | Merck & Co., Inc. | 0.00% | 83.38 | 0.7% | $683.91m | |
| BMY | Bristol-Myers Squibb Co. | 0.03% | 66.56 | 1.0% | $677.82m | |
| AZN | AstraZeneca Plc | 0.00% | 51.34 | 1.2% | $630.16m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 0.00% | 59.69 | 0.0% | $205.25m | |
| VTRS | Viatris, Inc. | 0.00% | 17.05 | 0.0% | $192.05m | |
| RPRX | Royalty Pharma Plc | 0.00% | 51.95 | 0.2% | $173.88m | |
| NVS | Novartis AG | 0.00% | 95.63 | 0.2% | $170.63m | |
| GSK | GlaxoSmithKline Plc | -0.01% | 38.47 | 0.2% | $140.21m | |
| SNY | Sanofi | 0.00% | 49.39 | 0.2% | $113.78m | |
| RGEN | Repligen Corp. | 0.00% | 215.47 | 6.9% | $75.65m | |
| NVO | Novo Nordisk A/S | 0.00% | 72.03 | 0.1% | $70.83m |
Company Profile
Oncternal Therapeutics, Inc. is a clinical-stage oncology company, which develops a diverse pipeline of treatments for cancers with critically unmet medical need. It focuses on drug development of untapped biological pathways implicated in cancer progression. The company was founded by David F. Hale and James B. Breitmeyer in 1997 and is headquartered in San Diego, CA.